SRRA
Sierra Oncology, Inc. Common Stock
SRRA
SRRA
Delisted
SRRA was delisted on the 30th of June, 2022.
60 hedge funds and large institutions have $76.5M invested in Sierra Oncology, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 15 increasing their positions, 17 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
60
Holders Change
-10
Holders Change %
-14.29%
% of All Funds
1.37%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
5
Increased
15
Reduced
17
Closed
15
Calls
$34K
Puts
–
Net Calls
+$34K
Net Calls Change
+$64K
Top Buyers
| 1 |
BC
Broadfin Capital
New York
|
+$3.37M |
| 2 |
PM
Prosight Management
Dallas,
Texas
|
+$1.55M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$932K |
| 4 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
+$828K |
| 5 |
Renaissance Technologies
New York
|
+$825K |
Top Sellers
| 1 |
DM
Deerfield Management
New York
|
-$5.22M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$3.04M |
| 3 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$2.37M |
| 4 |
PA
Perceptive Advisors
New York
|
-$2.21M |
| 5 |
Millennium Management
New York
|
-$1.41M |
